Chemoresistance and targeted therapies in ovarian and endometrial cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemoresistance and targeted therapies in ovarian and endometrial cancers

Published:2016-12-19 Issue:3 Volume:8 Page:4008-4042
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Brasseur Kevin¹,Gévry Nicolas²,Asselin Eric¹

Affiliation:

1. Research Group in Cellular Signaling, Department of Medical Biology, Canada Research Chair in Molecular Gyneco-Oncology, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada

2. Département de Biologie, Faculté des Sciences, Université de Sherbrooke, Boulevard de l’Université, Sherbrooke, QC, Canada

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on drug response genes to predict prognosis and therapeutic response in ovarian cancer;Heliyon;2024-07

2. The Endometrial Stem/Progenitor Cells and Their Niches;Stem Cell Reviews and Reports;2024-04-18

3. PI3K/AKT/MTOR SIGNALING PATHWAY - A KEY PLAYER IN THE MOLECULAR LANDSCAPE OF MALIGNANT TRANSFORMATION OF ORAL LESIONS;ROM J ORAL REHABIL;2024

4. Advances in research on autophagy mechanisms in resistance to endometrial cancer treatment;Frontiers in Oncology;2024-03-27

5. Dysregulation of calcium homeostasis in cancer and its role in chemoresistance;Cancer Drug Resistance;2024-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP